GlassScriptPhysician profile
Lisa A Reed
NPI 1477906998
$6,649.61
in general payments reported to CMS, 2019-2025
36 companies · $1,508 in 2025
The $1,508 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $767 · 2022: $1,869 · 2023: $2,481 · 2024: $24.98 · 2025: $1,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,719 · Travel and Lodging: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,718.57 |
| Travel and Lodging | $1,295.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,002.31 | 2022-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $765.49 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Si-Bone, INC. | $534.40 | 2022-2023 | |
| Abbvie INC. | $481.86 | 2021-2023 | |
| Collegium Pharmaceutical, INC. | $393.84 | 2021-2023 | Belbuca, Xtampza |
| Merz Pharmaceuticals, LLC | $205.25 | 2022-2023 | Xeomin |
| Vertos Medical, INC. | $196.19 | 2021-2023 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $185.83 | 2021-2023 | Ztlido |
| Abbott Laboratories | $180.37 | 2022-2025 | Proclaim, Eterna |
| Teva Pharmaceuticals USA, INC. | $179.04 | 2021-2023 | Ajovy |
| Lundbeck LLC | $172.00 | 2022-2023 | Vyepti |
| Arbor Pharmaceuticals, INC. | $157.76 | 2021-2022 | |
| Forte Bio-Pharma LLC | $156.72 | 2021-2023 | Prolate, Nalocet |
| Amgen INC. | $92.90 | 2021-2022 | |
| Lilly USA, LLC | $82.34 | 2021-2023 | Reyvow, Emgality |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.